Biocartis raises EUR 30 million in series E

Diagnostic company Biocartis S.A. (Lausanne, Switzerland) raised EUR 30 million ($40.5 million) from existing investors in a series E round. RMM; Debiopharm Group (Lausanne, Switzerland); PMV; Valiance; Johnson & Johnson Development Corp., the venture arm of Johnson & Johnson (NYSE:JNJ); Royal Philips Electronics N.V. (NYSE:PHG; Euronext:PHIA); the Wellcome Trust; and Petercam participated, along with Biocartis' founder and CEO Rudi Pauwels; and other individual investors, including some Biocartis employees. Biocartis raised EUR 34.5 million ($44.5 million) in a series D round in December. ...